BiomX acquires 10% stake in Motomea for $50K
What's the deal? BiomXDealroom has a profile for this one. Try Dealroom →, a US-listed defence technology company, has acquired a 10% stake in MotomeaDealroom has a profile for this one. Try Dealroom →, an Israeli-Indian developer of electric motor testing and validation systems. BiomX paid $50,000 in cash and agreed to issue 1,300,000 restricted shares to Motomea's majority owner, pending regulatory and NYSEDealroom has a profile for this one. Try Dealroom → approval. The deal also gives BiomX an exclusive licence to develop and distribute drone testing solutions.
What each side brings: BiomX builds technologies to detect, analyse and respond to physical threats. Motomea has more than 25 years in electric motor and rotating-machine testing, and patented the first load-free inertial dynamometer systems, which measure motor performance during acceleration and deceleration without an external mechanical load.
Why it matters: Electric motors shape flight time, payload, manoeuvrability and reliability in unmanned aerial systems. Defects can cut endurance and raise the risk of failure, making testing critical across development and production.
What's the endgame? BiomX also secured an option, at its sole discretion, to acquire control of Motomea after due diligence. If exercised, the price would combine shares and cash, based on 90% of the sum of two times Motomea's net revenue for fiscal 2027 and four times its EBITDA for fiscal 2028.
Under the agreement, Motomea will focus on electric propulsion testing for drones and aircraft. Its systems already serve major Israeli defence OEMs and civilian manufacturers internationally.
What they're saying: "Motomea brings BiomX a highly specialised engineering capability in an area that is central to modern unmanned systems," said Michael Oster, chief executive officer of BiomX. He added that Motomea's presence in the Indian subcontinent gives BiomX "a foothold in markets where it is seeking to expand."
The signal: The staged structure — a small stake plus an earnings-based option to control — lets BiomX test the fit before committing, while building out its Detection, Analysis and Response strategy in the drone and autonomous systems market.
Read more: ClarityPointe
Image credit: Generated with Gemini
